ScholarGate
助手

方法对比

并排查看您选择的方法;存在差异的行会高亮显示。

EORTC QLQ-LC13:肺癌生活质量×EORTC QLQ-BR23:乳腺癌生活质量×
领域肿瘤学肿瘤学
方法族Process / pipelineProcess / pipeline
起源年份19941996
提出者Bergman, B., et al. (EORTC Quality of Life Group)Sprangers, M. A., et al. (EORTC Quality of Life Group)
类型Self-report questionnaireSelf-report questionnaire
开创性文献Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗
别名QLQ-LC13QLQ-BR23
相关55
摘要The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.
ScholarGate数据集
  1. v1
  2. 2 来源
  3. PUBLISHED
  1. v1
  2. 2 来源
  3. PUBLISHED

前往搜索 下载幻灯片

ScholarGate方法对比: EORTC QLQ-LC13 · EORTC QLQ-BR23. 于 2026-06-19 检索自 https://scholargate.app/zh/compare